DAFTAR PUSTAKA 1. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non small cell lung cancer: Epidemiology, risk factors, treatment, and survioship. Mayo Clin Proc 2008; 83: 584-94 2. Rasyid R, Kamso S, Suratman E, Bestral. The characteristics and two-year survival rate of lung cancer patients at Dharmais Cancer Hospital in period January 1998-November 2001.available from: http://www.ekologi.litbang.depkes.go.id/ 3. Aditiawarman. Hubungan ketahanan hidup 1 tahun penderita kanker paru yang dirawat di RS Dr. Kariadi Semarang dengan faktor-faktor yang berhubungan. Karya akhir PPDS I. FK UNDIP, 2003.available from: http://www.eprints.undip.ac.id 4. World Health Organization. Passive Smoking Does Cause Lung Cancer. WHO:1998. 5. Buccheri G, Ferrigno D. Lung cancer: clinical presentation and specialist referral time. Eur Respir J 2004; 24: 898–904 6. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2:706-14 7. National Comprehensive Cancer Network Guidelines V 2.2013. Available from: http://www.nccn.org.. Accessed May 11, 2013 8. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D.Global cancer statistics. CA: a cancer journal for clinicians 2011; 61 (2): 69–90 9. American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society; 2012. 10. Lam PT, Leung MW, Tse CY. Identifying prognostic factors for survival in advanced cancer patients: A prospective study. Hong Kong: Med J ;2007; 13: 453-9 11. Josen K, Siegel R, Kamp D. Incidence and Epidemiology. In Weitberg AB. Cancer of the Lung From Melecular Biology to Treatment Guidelines. New Jersey. Humana Press; 2002 :3-26 12. Deaen W.Tumor Paru Di Daerah Toraks. In : Tiehua R, Yixin Z, Zongyuan Z, Jingqing L, Yilong W, Zhuming G. Buku Ajar Ankologi Klinis. Jakarta. Balai Penerbit FK UI; 2008: 337-50 58 59 13. Senby C. Neoplastic Disease. In : Respiratory Medicine. New York.Churchill Livingstone; 2002 : 54-9 14. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. 15. Haugen A, Mollerup S. Etiology of Lung Cancer. In : Hansen H. Lung Cancer. London. Informa Healthcare;2000: 1-8 16. Prokhorov AV, Ford KH, Hudmon KS. Smoking Cassation. In : Roth JA, Hong WK, Cox JD. Lung Cancer. USA. Blackwell Publishing;2008: 1-20 17. Boyle P, Gandini S, Gray N. Epidemiology of Lung Cancer: A Century of Great Success and Ignominious Failure. In : Hansen H. Textbook of Lung cancer. USA. Informa Healthcare; 2008:10-18 18. Ward JPT, Ward J, Leach RM, Wiener C. Kanker Paru In : At a Glance Sistem Respirasi. Jakarta. Arlangga;2007:84 19. Minaa JD: Neoplasma of The Lung.in Ed Principles of Internal Medicine.16th.McGraw-Hill Med Pub Div.2005.p 506-516 20. Jablonski A, Gift AG, Stommel M, Given CW. Symptom clusters in elderly patients with lung cancer. 2004 ;31(2), 203-212 21. Horn L, Pao W, Johnson DH (2012). "Chapter 89". In Longo, DL; Kasper, DL; Jameson, JL; Fauci, AS; Hauser, SL; Loscalzo, J. Harrison's Principles of Internal Medicine (ed. 18th). McGraw-Hill 22. Honnorat J, Antoine JC (May 2007). Paraneoplastic neurological syndromes"Orphanet Journal of Rare Diseases (BioMed Central) 2 (1): 22 23. Minna JD. Neoplasma of the lung. In Fauci AS, Braunwald E, Kasper DL, Hauser SL, et al. (editors) Harrison’s principles of internal medicine. 17th ed. New York. McGraw Hill. 2009:506 24. Brasher VL. Kanker paru. Dalam Devi Y. Aplikasi klinis patofisiologi, pemeriksaan dan manajemen. Cetakan I. Jakarta: Penerbit Buku Kedokteran EGC,2008 25. York E, Miller. Pathogenesis of Lung Cancer: Centennial Review. Am J Respir Mol Biol. 2005; 33.p216-223 26. Perhimpunan Dokter Paru Penatalaksanaan di Indonesia Indonesia(2003).Pedoman Diagnosis dan 27. Giaccone G. The potensial of antiangiogenic therapy in non-small cell lung cancer. Clin Can Resp 2007 60 28. Timbrel R.Lung Cancer : A review of current treatment modalities with a on new strategies. Eradimaging: 2009 29. Jusuf A, Mariono SA, Tambunan KL, Reksodiputro AA, Soetantio N, Hukom R, et al : Experience of treatment of lung cancer patients using paclitaxel and carboplatin. Med. J. Ind. 2000;9:43-8 30. Jeong HC, Lee SY, Lee SY, Kim JH, Shin C, Shim JJ, et al. Phase II study of irinotecan plus cisplatin with concurrent radiotherapy for the patients with limited-disease small-cell lung cancer. Lung Cancer 2006 Sep;53(3):361-6 31. Jusuf A, Harryanto A, Syahruddin E, Endardjo S, Mudjiantoro S, Sutantio N. Kanker paru jenis karsinoma bukan sel kecil. Pedoman Nasional untuk diagnosis dan penatalaksanaan di Indonesia 2005. Ed. Jusuf A,Syahruddin E. PDPI dan POI, Jakarta 2005 32. Supartono, Agus S. Faktor yang mempengaruhi ketahanan hidup penderita kanker paru di RSUP Dr. Kariadi Semarang. Med Hos. 2012; vol 1(1):25-31 33. Penninx BW, Cohen HJ, Woodman C. Anemia and cancer in older person. J Support Oncol 2007;5:107-113. 34. Sugiura S, Ando Y, Minami H, et all. Prognostic Value of pleural effusion in patients with non small cell lung cancer. Clinical Cancer Research 1997;3:47-50 35. Forest LM, McMillian, McArdle. A prospective longitudinal study of performance status, an inflamation based score and survival in patient with inoperable non small cell lung cancer. British Journal of Cancer 2005; 92, 1834-1836 36. Williamson JP, Phillips MJ, Hillman DR, Eastwood PR. Managing obstruction of the central airways.Intern Med J. 2010;40(6):399–410) 37. Nichols L, Saunders R, Friedrich. Cause of death of patient with lung cancer. Arch Pathol Lab Med. 2012;136:1552–1557 38. Metha A, Masrul B, Henny M. Hubungan karakteristik penderita dengan gambaran sitopatologi pada kasus karsinoma paru yang dirawat di RSUP Dr. M. Djamil Padang. J kes and. 2014;3(2) 39. Aziza I, Faisal, Elisna, Pudjo A, Heriawaty H, Juedo P. Kriteria diagnosis kanker paru berdasarkan gambaran morfologi pada ct-scan toraks. J kanker indo.2008; 1,3-8 40. Amira A, Elisna S, Wahju A, Indah S, Agus D. Analisis penyebab kematian pasien kanker paru. J respi indo.2014; 34:11-6 Lampiran 1 61 Lampiran 2 62 Lampiran 3 63 Biodata Mahasiswa Identitas Nama : Ardina Filindri Purba NIM : 22010111120044 Tempat tanggal lahir : Binjai, 07 Februari 1994 Jenis Kelamin : Perempuan Alamat : Jl. Taut gg Marjan NO 6, Medan No. Hp : 082272816102 Email : [email protected] Riwayat Pendidikan Formal : 1. SD : SDN 060786 MEDAN 2. SMP : SMP N 12 MEDAN 3. SMA : SMA N 1 MEDAN 4. SI : Fakultas Kedokteran Universitas Diponegoro